[Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia].
D000328:Adult; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004558:Electric Stimulation; D004562:Electrocardiography; D004594:Electrophysiology; D005260:Female; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic; D011342:Procainamide / Q000627:therapeutic use; D013610:Tachycardia / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D011342:Procainamide; D000638:Amiodarone
Valore e limiti dei test elettrofarmacologici nella selezione della terapia antiaritmica per le tachiaritmie ventricolari maligne.